The CEO of French consumer goods giant Danone on Wednesday downplayed the threat of obesity drugs on its food business. Antoine de Saint-Affrique told CNBC that surging demand for drugs like Wegovy ...
NEW YORK, Aug 11 (Reuters) - Danone (DANO.PA), opens new tab is introducing an Oikos brand drink targeting U.S. consumers using weight loss medications such as Wegovy, pledging the dairy-based ...
As the early signs of GLP-1-driven disruption emerge in the food sector, more manufacturers are exploring weight management-friendly innovation. The shift isn’t seismic yet, but momentum is building.
The market for GLP-1 medication is estimated by several forecasters to bring in over $100 billion in annual revenue within the next decade. But the drug category, initially developed for diabetes but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results